Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes

British Journal of Ophthalmology

Volumn 94, Issue 11, 2010, Pages 1464-1467

  Javadi, M A ^a   Feizi, Sepehr ^a   Karbasian, A ^b   Rastegarpour, A ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Sina Daru Pharmacy Co   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; CYCLOSPORIN A; PREDNISOLONE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; CONGENITAL CORNEA DYSTROPHY; KAPLAN MEIER METHOD; KERATOCONUS; METHODOLOGY; MIDDLE AGED; RECURRENT DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CORNEAL DYSTROPHIES, HEREDITARY; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; KERATOCONUS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78249257621     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.172577     Document Type: Article

References (20)

1. Javadi MA, Motlagh BF, Jafarinasab MR, et al. Outcomes of penetrating keratoplasty in keratoconus. Cornea 2005;24:941-6.
2. Price MO, Thompson RW, Price FW Jr. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol 2003;121:1087-92.
3. Wagoner MD, Ba-Abbad R, Sutphin JE, et al. Corneal transplant survival after onset of severe endothelial rejection. Ophthalmology 2007;114:1630-6.
4. Hudde T, Minassian DC, Larkin DF. Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection. Br J Ophthalmol 1999;83:1348-52.
5. Leibowitz H. Ocular toxicity of corticosteroids. In: Leopold IH, Burns RP, eds. Symposium on ocular therapy. Vol. 2. New York: John Wiley and Sons, 1979:108-9.
6. Belin MW, Bouchard CS, Phillips TM. Update on topical cyclosporine A. Background, immunology, and pharmacology. Cornea 1990;9:184-95.
7. Utech C, Wulle KG, Panitz N, et al. Immunosuppressive treatment of Graves' ophthalmopathy with cyclosporine A. Transplant Proc 1988;20:S173-7.
8. Kruit PJ, van Balen AT, Stilma JS. Cyclosporine A treatment in two cases of corneal peripheral melting syndrome. Doc Ophthalmol 1985;59:33-9.
9. Perry HD, Donnenfeld ED, Acheampong A, et al. Topical cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber. CLAO J 1998;24:159-65. (Pubitemid 28355243)
10. Belin MW, Bouchard CS, Frantz S, et al. Topical cyclosporine in high-risk corneal transplants. Ophthalmology 1989;96:1144-50. (Pubitemid 19196060)
11. Inoue K, Amano S, Kimura C, et al. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty. Jpn J Ophthalmol 2000;44:302-5.
12. Cosar CB, Laibson PR, Cohen EJ, et al. Topical cyclosporine in pediatric keratoplasty. Eye Contact Lens 2003;29:103-7.
13. Zhao JC, Jin XY. Local therapy of corneal allograft rejection with cyclosporine. Am J Ophthalmol 1995;119:189-94.
14. Price MO, Price FW Jr. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Ophthalmology 2006;113:1785-90.
15. Poon AC, Forbes JE, Dart JK. Systemic cyclosporine A in high-risk penetrating keratoplasties: a case-control study. Br J Ophthalmol 2001;85:1464-9.
16. Unal M, Yücel I. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts. Br J Ophthalmol 2008;92:1411-14.
17. Randleman JB, Stulting RD. Prevention and treatment of corneal graft rejection: current practice patterns 2004. Cornea 2006;25:286-90.
18. Williams KA, Erickson SA, Coster DJ. Topical steroid, cyclosporin A, and the outcome of rat corneal allografts. Br J Ophthalmol 1987;71:239-42.
19. Perry HD, Donnenfeld ED. Topical 0.05% cyclosporine in the treatment of dry eye. Expert Opin Pharmacother 2004;5:2099-107.
20. Panda A, Vanathi M, Kumar A, et al. Corneal graft rejection. Surv Ophthalmol 2007;52:375-96.